Particle.news

Download on the App Store

CAC 40 Rises as U.S. Jobless Claims Fall and Retail Sales Climb, Curtailing Fed Rate-Cut Expectations

Sanofi completes acquisition of Blueprint Medicines to reinforce its strategy in rare immunological diseases.

Des opérateurs à la Bourse de New York le 15 juillet 2025
La salle de contrôle d'Euronext, société qui gère la Bourse de Paris
Un opérateur à la Bourse de New York, le 18 juillet 2025
La salle de contrôle d'Euronext, société qui gère la Bourse de Paris

Overview

  • European stocks advanced broadly, with the CAC 40 gaining 0.58% to 7,867.50 as Wall Street logged fresh record highs this week.
  • U.S. weekly unemployment claims dropped to 221,000, underscoring persistent strength in the labor market.
  • June retail sales rose by 0.6%, driven by automotive and general merchandise spending, reinforcing signs of consumer resilience.
  • Investor forecasts for near-term Federal Reserve rate cuts have receded after firmer inflation readings and robust economic data, although Governor Christopher Waller’s proposal for a 25 basis-point cut in July is unlikely to secure FOMC support.
  • Sanofi completed its acquisition of Blueprint Medicines to strengthen its rare immunological disease portfolio and advance its global immunology strategy.